OPKO Health Gross Profit 2010-2024 | OPK

OPKO Health gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
OPKO Health Annual Gross Profit
(Millions of US $)
2023 $318
2022 $288
2021 $582
2020 $541
2019 $329
2018 $386
2017 $346
2016 $506
2015 $256
2014 $43
2013 $48
2012 $19
2011 $11
2010 $15
2009 $2
OPKO Health Quarterly Gross Profit
(Millions of US $)
2024-09-30 $40
2024-06-30 $52
2024-03-31 $42
2023-12-31 $45
2023-09-30 $48
2023-06-30 $126
2023-03-31 $99
2022-12-31 $56
2022-09-30 $31
2022-06-30 $116
2022-03-31 $85
2021-12-31 $109
2021-09-30 $142
2021-06-30 $150
2021-03-31 $182
2020-12-31 $176
2020-09-30 $155
2020-06-30 $139
2020-03-31 $71
2019-12-31 $82
2019-09-30 $87
2019-06-30 $82
2019-03-31 $78
2018-12-31 $72
2018-09-30 $99
2018-06-30 $114
2018-03-31 $101
2017-12-31 $4
2017-09-30 $95
2017-06-30 $135
2017-03-31 $112
2016-12-31 $12
2016-09-30 $147
2016-06-30 $204
2016-03-31 $144
2015-12-31 $133
2015-09-30 $76
2015-06-30 $28
2015-03-31 $20
2014-12-31 $14
2014-09-30 $9
2014-06-30 $11
2014-03-31 $10
2013-12-31 $9
2013-09-30 $9
2013-06-30 $11
2013-03-31 $20
2012-12-31 $7
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $2
2011-09-30 $3
2011-06-30 $4
2011-03-31 $3
2010-12-31 $8
2010-09-30 $2
2010-06-30 $3
2010-03-31 $2
2009-12-31 $-0
2009-09-30 $0
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.174B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $210.506B 96.57
Thermo Fisher Scientific (TMO) United States $202.042B 24.50
Alcon (ALC) Switzerland $44.047B 29.47
Edwards Lifesciences (EW) United States $42.914B 27.77
IDEXX Laboratories (IDXX) United States $37.709B 43.46
DexCom (DXCM) United States $35.463B 55.00
IQVIA Holdings (IQV) United States $34.295B 19.00
Mettler-Toledo (MTD) United States $27.400B 31.83
Waters (WAT) United States $22.520B 31.95
STERIS (STE) Ireland $21.977B 25.13
SONOVA HOLDING (SONVY) Switzerland $19.361B 0.00
Hologic (HOLX) United States $14.588B 15.74
Fresenius Medical Care AG KGaA (FMS) Germany $13.679B 14.04
Sysmex ADR (SSMXY) Japan $11.343B 35.57
Penumbra (PEN) United States $11.081B 100.24
Globus Medical (GMED) United States $10.896B 25.48
Masimo (MASI) United States $9.140B 44.23
Teleflex (TFX) United States $8.250B 13.16
Glaukos (GKOS) United States $6.850B 0.00
Integer Holdings (ITGR) United States $4.269B 23.96
PROCEPT BioRobotics (PRCT) United States $3.400B 0.00
Veracyte (VCYT) United States $3.050B 55.44
LivaNova (LIVN) United Kingdom $2.688B 15.52
Nihon Kohden (NHNKY) Japan $2.652B 14.49
TransMedics (TMDX) United States $2.588B 82.04
Elekta AB (EKTAY) Sweden $2.198B 19.76
Tandem Diabetes Care (TNDM) United States $2.145B 0.00
Integra LifeSciences Holdings (IART) United States $1.701B 8.89
Alphatec Holdings (ATEC) United States $1.526B 0.00
RxSight (RXST) United States $1.181B 0.00
Artivion (AORT) United States $1.167B 111.40
Pulse Biosciences (PLSE) United States $1.154B 0.00
Paragon 28 (FNA) United States $1.092B 0.00
Beta Bionics (BBNX) United States $0.883B 0.00
AxoGen (AXGN) United States $0.793B 0.00
Mesa Laboratories (MLAB) United States $0.791B 17.30
SiBone (SIBN) United States $0.733B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.718B 12.21
IRadimed (IRMD) United States $0.699B 36.76
ORTHOFIX MEDICAL INC (OFIX) United States $0.694B 0.00
Treace Medical Concepts (TMCI) United States $0.597B 0.00
OrthoPediatrics (KIDS) United States $0.569B 0.00
ClearPoint Neuro (CLPT) United States $0.452B 0.00
Delcath Systems (DCTH) United States $0.449B 0.00
Pacific Biosciences Of California (PACB) United States $0.446B 0.00
Semler Scientific (SMLR) United States $0.411B 9.04
AngioDynamics (ANGO) United States $0.408B 0.00
NeuroPace (NPCE) United States $0.404B 0.00
Tactile Systems Technology (TCMD) United States $0.351B 18.86
CVRx (CVRX) United States $0.343B 0.00
Anteris Technologies Global (AVR) Australia $0.261B 0.00
Inogen (INGN) United States $0.234B 0.00
Nevro (NVRO) United States $0.214B 0.00
Accuray (ARAY) United States $0.212B 0.00
Alpha Tau Medical (DRTS) Israel $0.192B 0.00
KORU Medical Systems (KRMD) United States $0.169B 0.00
Spectral Diagnostics (EDTXF) Canada $0.151B 0.00
Neuronetics (STIM) United States $0.135B 0.00
Sight Sciences (SGHT) United States $0.125B 0.00
Rapid Micro Biosystems (RPID) United States $0.121B 0.00
LENSAR (LNSR) United States $0.108B 0.00
Atossa Genetics (ATOS) United States $0.099B 0.00
InspireMD (NSPR) Israel $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.093B 0.00
908 Devices (MASS) United States $0.089B 0.00
Sensus Healthcare (SRTS) United States $0.085B 12.98
Lucid Diagnostics (LUCD) United States $0.082B 0.00
Vicarious Surgical (RBOT) United States $0.081B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Covalon Technologies (CVALF) Canada $0.055B 16.58
Microbot Medical (MBOT) United States $0.054B 0.00
Positron (POSC) United States $0.052B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Baird Medical Investment Holdings (BDMD) $0.029B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.021B 0.00
Biosig Technologies (BSGM) United States $0.016B 0.00
WORK Medical Technology Group (WOK) China $0.014B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
Aspira Women's Health (AWH) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00